Burke Steven Keith - Insider Non-Derivative Transactions at Akebia Therapeutics, Inc. (AKBA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 29, 2024, Burke Steven Keith's relationship to Akebia Therapeutics, Inc. (AKBA) is Officer (SVP, Chief Medical Officer), and currently has 695,840 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AKBA insiders.
Data Source: SEC.
Burke Steven Keith - Insider Non-Derivative Transactions of AKBA Common Stock
Burke Steven Keith - Insider Non-Derivative Transactions at AKBA
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Mar 1, 2024 | Sell -- (Common Stock) | 7169 | 1.58 | 695840 |
Feb 28, 2024 | Sell -- (Common Stock) | 8367 | 1.52 | 703009 |
Feb 2, 2024 | Sell -- (Common Stock) | 24311 | 1.68 | 711376 |
Feb 1, 2024 | Acquisition -- (Common Stock) | 202200 | 0 | 735687 |
Aug 26, 2023 | Sell -- (Common Stock) | 27000 | 1.15 | 668840 |
May 17, 2023 | Sell -- (Common Stock) | 63567 | 1.07 | 530487 |
Mar 2, 2023 | Sell -- (Common Stock) | 1110 | 0.88 | 594054 |
Mar 2, 2023 | Sell -- (Common Stock) | 6400 | 0.88 | 595164 |
Mar 2, 2023 | Sell -- (Common Stock) | 6613 | 0.88 | 601564 |
Feb 28, 2023 | Sell -- (Common Stock) | 7539 | 0.81 | 608177 |
Feb 1, 2023 | Acquisition -- (Common Stock) | 196200 | 0 | 615716 |